@article{ATM29037,
author = {Paolo Bironzo and Francesco Passiglia and Silvia Novello},
title = {Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 6},
year = {2019},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICIs) directed against programmed cell death protein 1(PD-1) and its ligand (PD-L1) have rapidly changed non-small cell lung cancer (NSCLC) treatment paradigms, leading to unprecedented results, both in metastatic and locally advanced disease.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/29037}
}